Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1061-1070

  Medina, Maite ^a   Vélez, Desireé ^a   Asenjo, José A ^a   Egea, Gustavo ^b   Real, Francisco X ^c   Gil, Juana ^a,d   Subiza, José L ^a,e  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; MONOCLONAL ANTIBODY; MUCIN;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BRONCHUS MUCOSA; CELL ULTRASTRUCTURE; COLON ADENOCARCINOMA; EHRLICH ASCITES TUMOR CELL; EPITHELIUM CELL; EPITOPE MAPPING; FROZEN SECTION; GLYCOSYLATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CA-15-3 ANTIGEN; CARBOHYDRATE SEQUENCE; CARCINOMA, EHRLICH TUMOR; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; INTESTINAL MUCOSA; MICE; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 0344142379     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hakomori, S-I. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res., 52: 257-331, 1989.
2. Lesuffleur, T., Zweibaum, A., and Real, F. X. Mucins in normal and neoplastic human gastrointestinal tissues. CRC Crit. Rev. Oncol., 17: 153-180, 1994.
3. Itzkowitz, S. H., Dahiya, R., Byrd, J. C., and Kim, Y. S. Blood group antigen synthesis and degradation in normal and cancerous colonic tissues. Gastroenterology. 99: 431-442, 1990.
4. Feizi, T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature (Lond.), 314: 53-57, 1985.
5. Gil, J., Alvarez, R., Viñuela, J. E., Ruiz, de Morales, J. G., Bustos, A., De la Concha, E. G., and Subiza, J. L. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates. Cancer Res., 40: 7301-7306, 1990.
6. Subiza, J. L., Gil, J., Rodríguez, R., Ruiz de Morales, J. G., Viñuela, J., and De la Concha, E. G. Tumor cytostasis mediated by a monoclonal IgM antibody promoting adhesion between macrophages and tumor cells. J. Immunol., 148: 2636-2642, 1992.
7. Vinuela, J., Rodriguez, R., Gil, J., Coll, J., De La Concha, E. G., and Subiza, J. L. Antigen shedding vs development of natural suppressor cells as mechanism of tumor escape in mice bearing Ehrlich tumor. Int. J. Cancer. 47: 86-91, 1991.
8. Subiza, J. L., Coll, J., Alvarez, R., Valdivieso, M., and De La Concha, E. G. IgM response and resistance to ascites tumor growth. Cancer Immunol. Immunother., 25: 87-92, 1987.
9. Lesuffleur, T., Barbat, A., Dussaulx, E., and Zweibaum, A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res., 50: 6334-6343, 1990.
10. Xing, P. X., Reynolds, K., Tjandra, J. J., Tang, X. L., and McKenzie, I. F. C. Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res., 50: 89-98, 1990.
11. Xing, P. X., Apostopoulos, V., Prenzoska, J., Devine, P. L., and McKenzie, I. F. C. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J. Natl. Cancer Inst., 84: 699-703, 1992.
12. Gambús, G., de Bolós, C., Andreu, D., Francí, C., Egea, G., and Real, F. X. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenlerology, 104: 93-102, 1993.
13. Egea, G., Franci, C., Gambús, G., Lesuffleur, T., Zweibaum, A., and Real, F. X. cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells. J. Cell Sci., 105: 819- 830, 1993.
14. Edge, A. S. B., Faltynek, C. R., Hof, L., Reichert, L. E., Jr., and Weber, P. Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal. Biochem., 118: 131-137, 1981.
15. Devine, P. L., Clark, B. A., Birrel, G. W., Layton, G. T., Ward, B. G., Alewood, P. F., and McKenzie, I. F. C. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res., 51: 5826-5836, 1991.
16. Spiro, R. G. Study of the carbohydrates of glycoproteins. Methods Enzymol., 28: 35-35, 1972.
17. Spiro, R. G. Analysis of sugar found in glycoproteins. Methods Enzymol., 8: 47-49, 1966.
18. Strous, G. J., and Dekker, J. Mucin-type glvcoproteins. Crit. Rev. Biochem. Mol. Biol., 27, 57-92, 1992.
19. Itzkowitz, S. Carbohydrate changes in colon carcinoma. Acta Pathol. Microbiol. Immunol. Scand., 100 (Suppl. 27): 173-180, 1992.
20. x expression. Cancer Res., 53: 4082-4088, 1993.
21. Hanisch, F. G., and Baldus, S. E. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Histol. Histopathol., 12: 263-281, 1997.
22. x-related antigen expression in human malignant and nonmalignant colonic tissues. Cancer Res., 46: 2627-2632, 1986.
23. 6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res., 45: 3711-3717, 1985.
24. Hanisch, F. G., Heimbhchel, G., Baldus, S. E., Uhlenbruck, G., Schmits, R., Pfreundschuh, M., Schwonzen, M., Vierbuchen, M., Bara, J., and Peter-Katalinic, J. Monoclonal antibody FW6 defines an epitope on α3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins. Cancer Res., 53: 4367-4375, 1993.
25. Forstner, J. F., and Neutra, M. R. Gastrointestinal mucus: synthesis, secretion, and function. In: L. Johnson (ed.), Physiology of the Intestinal Tract, Ed. 2, pp. 975-1009, New York: Raven Press, 1987.
26. Carrato, C., Balagué, C., De Bolos, C., Gonzalez, E., Gambús, G., Planas, J., Perini, J. M., Andreu, D., and Real, F. X. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology, 107: 160-172, 1994.
27. Gendler, S. J., Burchell, J. M., Duhig, T., Lamport, D., White, R., Parker, M., and Papadimitriou, J. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc. Natl. Acad. Sci. USA, 84: 6060-6064, 1987.
28. Ho, J. J. L., and Kim, Y. S. Serological pancreatic tumor markers and the MUC1 apomucin. Pancreas, 9: 674-691, 1994.
29. Stacker, S. A., Tjandra, J. J., Xing, P-X., Walker, I. D., Thompson, C. H., and McKenzie, I. F. C. Purification and biochemical characterization of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2. Br. J. Cancer. 59: 544-553, 1989.
30. Hertzog, P. J., Robinson, H. C., Ma, J., Mackay, I. R., and Linnane, A. W. Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies. Int. J. Cancer. 48: 355-363, 1991.
31. Atkinson, B. F., Ernest, C. S., Herlyn, M., Steplewski, Z., Sear, H. F., and Koprowski, H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res., 42: 4820-4823, 1982.
32. Goodgam, R., Kiefe, C., Ruse, E., Sulton, F., Brown, J., and Alpert, E. Clinical evaluation of M43: a novel cancer-associated mucin epitope. Cancer Res., 53: 2803-2809, 1993.
33. Mattes, M, J., Look, K., and Lewis, J. L. Three mouse monoclonal antibodies to human differentiation antigens: reactivity with two mucin-tike antigens and with connective tissues fibers. J. Histochem. Cytochem. 33: 1095-1099, 1985.
34. Kuan. S-F., Byrd, J. C., Basbaum, B., and Kim, Y. S. Inhibition of mucin glycosylation by aryl-N-acetyl-α-galactosaminides in human colon cancer cells. J. Biol. Chem., 264: 19271-19277, 1989.
35. Duksin, D., and Mahoney, W. C. Relationship of the structure and biological activity of the natural homologues of tunicamycin. J. Biol. Chem., 257: 3105-3109, 1982.
36. Bharathan, S., Moriarty, J., Moody, C. E., and Sherblom, A. P. Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells. Cancer Res., 50: 5250-5256, 1990.
37. Hanish, F. G., Stadie, T. and Bosslet, K. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaceharide linked to threonine with the VTSA motif of MUC1 tandem repeats. Cancer Res., 55: 4036-4040, 1995.
38. Apostolopoulos, V., Osinki, C., and McKenzie, I. F. C. MUC1 cross-reactive Galα(1.3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat. Med., 4: 315-320, 1998.
39. Umemoto, J., Matta, K. L., Barlow, J. J., and Bhavanandan, V. P. Action of endo-α-N-acetyl-D-galactosaminidase on synthetic glycosides including chromogenic substrates. Anal. Biochem., 91: 186-193, 1978.
40. Podolsky, D. K. Oligosaccharide structures of isolated human colonic mucin species. J. Biol. Chem., 260: 15510-15515, 1985.
41. Brockhausen, I., Romero, P. A., and Herscovics, A. Glycosyltransferase changes upon differentiation of Caco-2 human colonie adenocarcinoma cells. Cancer Res., 51: 3136-3142, 1991.
42. Brockhausen, I., Yang, J. M., Burchell, J., Whitehouse, C., and Taylor-Papadimitriou, J. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem., 233: 607-617, 1995.
43. Hull, S. R., Bright, A., Carraway, K. L., Abe, M., Haves, D. F., and Kufe, D. W. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun., 1: 261-267, 1989.
44. Manisch, F. G., Stadie, T. R. E., Deutzmann, F., and Peter-Katalinic, J. MUC1 glycoforms in breast cancer. Cell line T47D as a model for carcinoma-associated alterations of O-glycosylation. Eur. J. Biochem., 236: 318-327, 1996.
45. Lloyd, K. O., Burchell, J., Kudryashov, V., Yin, B. W. T., and Taylor-Papadimi-triou, J. Comparison of O-linked carbohydrate chains in MUC1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem., 271: 33325-33334, 1996.
46. Van Halbeek, H., Vliegenthart, J. F. G., Fiat, A. M., and Jollés, P. Isolation and structural characterization of the smaller-size oligosaccharides from desialylated human τ-casein. Establishment of a novel type of core for a mucin-type carbohydrate chain. FEBS Lett., 187: 81-88, 1985.
47. Hounsell, E. F., Lawson, A. M., Feeney, J., Gool, H. C., Pickering, N. J., Stell, M. S., Lui, S. C., and Feizi, T. Structural analysis of the O-glycosidically linked core-region oligosaccharides of human meconium glycoproteins which express oncofoelal antigens. Eur. J. Biochem., 148: 361-377, 1985.
48. Springer, G. F. T and Tn, general carcinoma antigens. Science (Washington DC), 224: 1198-1206, 1984.
49. Codington, J. F., and Haavik, S. Epiglycanin: a carcinoma-specific mucin-type glycoprotein of the mouse TA3 tumour. Glycohiology, 2: 173-180, 1992.